Renal Division, Peking University First Hospital, Peking University Institute of Nephrology, Key Laboratory of Renal Disease, Ministry of Health of China, Key Laboratory of CKD Prevention and Treatment, Ministry of Education of China, Beijing 100034, PR China.
Department of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Urological Cancer Center of China, Beijing 100034, PR China.
Int Immunopharmacol. 2021 Feb;91:107282. doi: 10.1016/j.intimp.2020.107282. Epub 2020 Dec 25.
There are few studies describing the prevalence and immune features of people with subclinical mesangial immunoglobulin A (IgA) deposition in the Chinese population. We sought to investigate the prevalence of mesangial IgA deposition among kidney donors and the immune characteristics of donors with mesangial IgA deposition.
Fifty blood-related living donors with zero-hour allograft biopsies obtained at Peking University First Hospital were enrolled. Galactose-deficient IgA1 (Gd-IgA1) in glomerular deposits was examined by double immunofluorescent staining using the specific monoclonal antibody KM55. Plasma IgA, IgA1, Gd-IgA1 and antibodies directed against Gd-IgA1 were measured using enzyme-linked immunosorbent assay.
Thirteen of 50 (26%) donors had mesangial IgA deposition, which was confirmed by both immunofluorescence and electron microscopy. The levels of plasma IgA, IgA1 and Gd-IgA1 were all increased in donors with IgA deposition compared with those without IgA deposition (mean ± SD, 3.54 ± 0.505 versus 2.356 ± 0.265 mg/ml, p = 0.049; 3.003 ± 0.4048 versus 2.356 ± 0.265 mg/ml, p = 0.057; and 4.719 ± 0.4357 versus 3.356 ± 0.4707 ug/ml, p = 0.0440, respectively). Colocalized IgA1 and Gd-IgA1 indicated that there were galactose-deficient IgA1 deposits in the glomerular mesangium. While donors with IgA deposition showed lower levels of IgG anti-glycan antibodies than patients with IgA nephropathy (37.71 ± 8.886 versus 78.86 ± 5.155 units/ml, p = 0.001).
The immune features of donors with IgA deposition, including IgA1 and Gd-IgA1 deposition, were similar to those of patients with IgA nephropathy, but donors with IgA deposition had lower levels of antiglycan antibodies, which may explain the subclinical status of IgA deposition in donors. Mesangial IgA deposition was common in the Chinese blood related donors cohort, further large study with both living and cadaveric donor kidneys was still needed to confirm these findings.
描述中国人群亚临床系膜免疫球蛋白 A(IgA)沉积的患病率和免疫特征的研究较少。我们旨在调查肾供体中系膜 IgA 沉积的患病率以及系膜 IgA 沉积供体的免疫特征。
纳入 50 名在北京大学第一医院接受零时同种异体肾活检的血相关活体供体。使用特异性单克隆抗体 KM55 通过双重免疫荧光染色检查肾小球沉积物中的半乳糖缺乏 IgA1(Gd-IgA1)。使用酶联免疫吸附试验测量血浆 IgA、IgA1、Gd-IgA1 和针对 Gd-IgA1 的抗体。
50 名供体中有 13 名(26%)存在系膜 IgA 沉积,免疫荧光和电子显微镜均证实了这一点。与无 IgA 沉积的供体相比,有 IgA 沉积的供体的血浆 IgA、IgA1 和 Gd-IgA1 水平均升高(均值±标准差,3.54±0.505 与 2.356±0.265mg/ml,p=0.049;3.003±0.4048 与 2.356±0.265mg/ml,p=0.057;和 4.719±0.4357 与 3.356±0.4707μg/ml,p=0.0440,分别)。共定位的 IgA1 和 Gd-IgA1 表明肾小球系膜中有半乳糖缺乏的 IgA1 沉积。与 IgA 肾病患者相比,有 IgA 沉积的供体的 IgG 抗糖抗体水平较低(37.71±8.886 与 78.86±5.155 单位/ml,p=0.001)。
包括 IgA1 和 Gd-IgA1 沉积在内的有 IgA 沉积供体的免疫特征与 IgA 肾病患者相似,但有 IgA 沉积的供体的抗糖抗体水平较低,这可能解释了供体中 IgA 沉积的亚临床状态。系膜 IgA 沉积在中国人血相关供体队列中很常见,仍需要对活体和尸体供体肾脏进行更大的研究来证实这些发现。